IVD，許可申請和交換生態系統：醫療創新的新時代

IVD醫療控股先驅A'Newco+RWA'Web3交換生態系統，旨在徹底改變醫療資產流動性和價值轉換。發現其Stablecoin許可申請的含義。

IVD, License Application, and the Exchange Ecosystem: A New Era for Medical Innovation

IVD，許可申請和交換生態系統：醫療創新的新時代

In the dynamic world of digital finance and medical breakthroughs, a groundbreaking initiative is taking shape. IVD Medical Holding is forging a path with its 'NewCo+RWA' Web3 exchange ecosystem, designed to transform how medical assets are valued and exchanged.

在數字金融和醫療突破的動態世界中，一項開創性的計劃正在形成。 IVD醫療控股公司正在使用其“ Newco+RWA” Web3 Exchange生態系統開闢道路，旨在改變醫療資產的重視和交換方式。

IVD Medical Holding's Bold Move

IVD醫療控股的大膽舉動

IVD Medical Holding (01931.HK) is strategically positioning itself to capitalize on the US 'Genius Act' with its IVDD stablecoin plan. This initiative aims to establish a novel global infrastructure for medical innovative drugs RWA (Real World Assets). Their approach centers on constructing a 'NewCo+RWA' Web3 exchange ecosystem (IVDNewCo Exchange), underpinned by the 'IVDDollar' (IVDD) stablecoin. This is all about digitally revolutionizing global medical innovation assets.

IVD醫療控股（01931.HK）從戰略上定位了自己的IVDD Stablecoin計劃，以利用美國的“天才法”。該計劃旨在為醫學創新藥物RWA（現實世界資產）建立新的全球基礎設施。他們的方法集中在構建“ newco+rwa” Web3交換生態系統（IVDNewco Exchange）的基礎上，該生態系統（IVDDollar'（IVDD）（IVDD）StableCoin為基礎。這全都是關於將全球醫學創新資產革新的。

Strategic Opportunities Under Global Regulatory Resonance

全球監管共鳴的戰略機會

With the US 'Genius Act' establishing stablecoins as 'digital dollars' and Hong Kong's Stablecoin Ordinance, IVD Medical is strategically aligned with global regulatory trends. By proactively pursuing a US stablecoin license through its US subsidiary, IVD GROUP INC., the company aims to be a frontrunner in compliant digital finance for medical innovation.

隨著美國的“天才法案”將穩定的人建立為“數字美元”和香港的Stablecoin條例，IVD醫學在戰略上與全球監管趨勢保持一致。通過通過其美國子公司IVD Group Inc.積極尋求美國穩定許可證，該公司的目標是成為合規數字融資醫療創新的領先者。

Technological Innovation: Reconstructing the Value Chain

技術創新：重建價值鏈

The IVDNewCo Exchange ecosystem's core breakthrough lies in integrating Web3 technology with medical innovative drug assets. By tokenizing innovative drug assets and establishing a compliance financial infrastructure, IVD Medical aims to improve financing efficiency and lower investor entry barriers. The idea is to convert innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets.

IVDNEWCO交換生態系統的核心突破在於將Web3技術與醫學創新藥物資產整合在一起。通過對創新的毒品資產進行統治並建立合規性基礎設施，IVD Medical旨在提高融資效率並降低投資者進入障礙。這個想法是將臨床階段的ADC藥物，雙抗體療法和細胞基因療法等創新的藥物資產轉換為可貿易且可分割的數字證書，以破壞傳統醫療資產的流動性瓶頸。

The Exchange Ecosystem: A Closer Look

交換生態系統：仔細觀察

The IVDNewCo Exchange ecosystem represents a paradigm shift in medical finance. By enabling the monetization of clinical-stage assets, IVD Medical provides pharmaceutical companies with low-cost financing and investors with dynamic returns linked to drug development progress. This has the potential to reshape the value chain of innovative medical drugs.

IVDNEWCO交換生態系統代表了醫療金融的範式轉變。通過實現臨床資產的貨幣化，IVD Medical為製藥公司提供低成本融資和投資者，並具有與藥物開發進度有關的動態回報。這有可能重塑創新醫學藥物的價值鏈。

Industry Impact and Future Outlook

行業影響和未來前景

IVD Medical's strategic moves have garnered significant attention, reflected in its share price surge. As the company continues to deepen its compliance, technology, and ecological integration strategies, it aims to bridge traditional medical capital with digital financial innovation. They envision the IVDNewCo Exchange ecosystem as a value amplifier for global innovative medical drug assets, benefiting patients, pharmaceutical companies, and investors alike.

IVD Medical的戰略舉動引起了極大的關注，這反映在其股價上漲。隨著公司繼續加深其合規性，技術和生態整合策略，它旨在通過數字金融創新橋接傳統的醫療資本。他們將IVDNEWCO交換生態系統視為全球創新醫學藥物資產的價值放大器，使患者，製藥公司和投資者都受益。

Final Thoughts

最後的想法

So, will IVD Medical Holding’s ambitious plan to create a compliant and innovative exchange ecosystem for medical assets pay off? Only time will tell, but one thing's for sure: they're shaking things up in the world of medical finance. Keep an eye on this space – it’s gonna be interesting!

因此，IVD醫療控股公司的雄心勃勃的計劃是否會為醫療資產創建合規，創新的交換生態系統嗎？只有時間會說明，但可以肯定的是：他們在醫療金融領域搖晃了事情。密切關注這個空間 - 這將很有趣！